Pregnancy Outcomes Associated with Introduction of Early Diabetes Screening Guidelines

Abstract

Objective The study aimed to evaluate perinatal outcomes associated with introduction of and adherence to early diabetes screening guidelines.

Study Design Retrospective cohort study of all women who received prenatal care at a single, high-volume tertiary care center before (“preguidelines”) and after (“postguidelines”) American College of Obstetrics and Gynecology guidelines for early pregnancy diabetes screening for women at high risk for diabetes. Women with known pregestational diabetes, late entry to prenatal care, a fetus with a known anomaly, or multiple gestation were excluded. Multivariable linear and logistic regression models were constructed to compare maternal and neonatal outcomes between women in the preguidelines cohort to those in the postguidelines cohort. Similarly, adherence to screening guidelines was assessed, and among all women who were eligible for early diabetes screening, multivariable linear, and logistic models were created to compare outcomes between those women who were screened early to those who were not.

Results Of the 2,069 women eligible for analysis, 64.6% (n = 1,337) were in the postguideline cohort. Women in the postguideline cohort were older, less likely to have a history of smoking, and more likely to be non-Hispanic white. On multivariable analysis, women in the postguideline cohort had significantly less gestational weight gain (aβ = −2.3; 95% confidence interval [CI]: −3.4 to −1.1), but a higher odds of 5-minute Apgar's score of <7 (adjusted odds ratio: 2.51; 95% CI: 1.11–5.66). Of 461 women who met ACOG early diabetes screening criteria, 58.7% (n = 270) were screened appropriately. Adherence to screening was associated with parity, race, insurance, and BMI. On multivariable analysis, there were no significant differences in neonatal outcomes between women meeting early screening criteria who were screened early and those who were not.

Conclusion Introduction of early diabetes screening guidelines was associated with a significant decrease in gestational weight gain, but did not improve neonatal outcomes.

Key Points

• Introduction of early diabetes screening guideline did not improve rate of early screening.

• Detection and treatment of gestational diabetes may not improve perinatal outcomes.

• Early screening guidelines was associated with decreased gestational weight.

Keywords

gestational diabetes - early screening - pregnancy outcomes - guideline adherence

Note

The study was presented as a poster at the 2019 Society for Maternal Fetal Medicine 39th Annual Meeting, Las Vegas, NV, February 2019.

Publikationsverlauf

Eingereicht: 20. August 2020

Angenommen: 04. November 2020

Artikel online veröffentlicht:
22. Dezember 2020

• References

• 1 Deputy NP, Kim SY, Conrey EJ, Bullard KM. Prevalence and changes in preexisting diabetes and gestational diabetes among women who had a live birth - United States, 2012-2016. Morb Mortal Wkly Rep 2018; 67 (43) 1201-1207
• 2 Metzger BE, Lowe LP, Dyer AR. et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358 (19) 1991-2002
• 3 Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352 (24) 2477-2486
• 4 Moyer VA, Force USPST. U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. preventive services task force recommendation statement. Ann Intern Med 2014; 160 (06) 414-420
• 5 Metzger BE, Gabbe SG, Persson B. et al; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33 (03) 676-682
• 6 American College of Obstetricians and Gynecologists (ACOG). Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynecol 2013; 122 (2 Pt 1): 406-416
• 7 American Diabetes Association. 14. Management of diabetes in pregnancy: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43 (Suppl. 01) S183-S192
• 8 Mission JF, Catov J, Deihl TE, Feghali M, Scifres C. Early pregnancy diabetes screening and diagnosis: prevalence, rates of abnormal test results, and associated factors. Obstet Gynec 2017; 130 (05) 1136-1142
• 9 Hong WY, Biggio JR, Tita A, Harper LM. Impact of early screening for gestational diabetes on perinatal outcomes in high-risk women. Am J Perinatol 2016; 33 (08) 758-764
• 10 Sweeting AN, Ross GP, Hyett J. et al. Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care 2016; 39 (01) 75-81
• 11 Feghali MN, Abebe KZ, Comer DM, Caritis S, Catov JM, Scifres CM. Pregnancy outcomes in women with an early diagnosis of gestational diabetes mellitus. Diabetes Res Clin Pract 2018; 138: 177-186
• 12 Immanuel J, Simmons D. Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and metaanalysis. Curr Diab Rep 2017; 17 (11) 115
• 13 Ryan DK, Haddow L, Ramaesh A. et al. Early screening and treatment of gestational diabetes in high-risk women improves maternal and neonatal outcomes: a retrospective clinical audit. Diabetes Res Clin Pract 2018; 144: 294-301
• 14 Harper LM, Jauk V, Longo S. et al. Early gestational diabetes screening in obese women: a randomized controlled trial. Am J Obstet Gynecol 2020; 222 (05) 495.e1-495.e8
• 15 American College of Obstetricans and Gynecologists (ACOG). Practice bulletin no. 190: gestational diabetes mellitus. Obstet Gynec 2018; 131 (02) e49-e64